The Medicare GLP-1 Bridge Program launched July 1, 2026, charging eligible Part D enrollees a flat $50 per month co-pay for certain GLP-1 medications prescribed for obesity
Compounded semaglutide injections from PlexusDx are $189/mo month-to-month, or from $149/mo on the 6-month plan flatthe same price whether your dose is 0.25 mg or 2.4 mg
Writing in the Journal of the American Medical Association (JAMA), this week, a team of WHO directors and advisors argued that the availability of GLP-1 therapies should galvanize the global community to build a fair, integrated, and sustainable obesity ecosystem. Nearly one in five Americans have used a GLP-1 therapy at least once
Antioxidants role in regulating oxidative stress
Lipotropic injections can support this by enhancing the breakdown of fat, which may help individuals with insulin resistance burn more calories from stored fat
The outer thigh provides an alternative location with good fat depth and is convenient for patients who prefer non-abdominal sites